Abstract
Updated Follow-up of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (SB-525) Gene Therapy in Adults with Severe Hemophilia a
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have